Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]
Elekta
Elekta inks oncology co-selling deal with IBM Watson Health
Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer […]
Elekta taps Brainlab as US stereotactic neurosurgery distro partner
Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance […]
Elekta delays rollout for Unity MR-radiation therapy combo
Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the […]
Elekta inks stereotactic development, software, co-marketing deals
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. […]
Elekta taps Brainlab as select EU distro partner for stereotactic neuro devices
Elekta (STO:EKTA B) said today it tapped Brainlab to distribute its stereotactic neurological devices across select markets in the European Union. The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance […]
Feds charge ex-Medicare employees with insider trading
Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme, federal prosecutors and the U.S. Securities & Exchange Commission alleged today. An SEC lawsuit and a criminal complaint accuse political consultant David Blaszczak, founder of Precipio Health Strategies […]
Shockwave Medical picks up ex-HeartWare CEO Godshall | Personnel Moves – May 11, 2017
Shockwave Medical said today it tapped former HeartWare CEO Doug Godshall as its new prez & CEO. Godshall served as CEO of HeartWare for 10 years until the business was acquired by Medtronic (NYSE:MDT) for $1.1 billion last August, Fremont, Calif.-based Shockwave Medical said. Prior to his time at HeartWare, Godshall held various executive and leadership […]
Varian Medical, Elekta bury the hatchet in radiosurgery spat
Varian Medical (NYSE:VAR) and Elekta (STO:EKTA B) said yesterday that they agreed to bury the hatchet in their patent infringement war over radiosurgery technology. The agreement covers litigation in the U.S., Germany and the U.K. and includes a lawsuit brought by Elekta and William Beaumont Hospital in Royal Oak, Mich., Varian and Elekta said. The settlement did not involve […]
Elekta wins Health Canada nod for Leksell Gamma Knife Icon SRS system
Elekta (STO:EKTA B) said today it won Health Canada approval for its Leksell Gamma Knife Icon radiosurgery system. The Stockholm, Sweden-based company touted its Leksell Gamma Knife Icon radiosurgery system as the only SRS system designed specifically for targeting brain tissue. The Icon is the 6th generation version of the radiosurgery system from the Elekta. “Robust clinical […]
Elekta wins FDA 510(k) clearance for Venezia gynecological brachytherapy applicator
Elekta (STO:EKTA B) said today it won FDA 510(k) clearance for its Venezia applicator for gynecological brachytherapy, now cleared for the treatment of advanced-stage cervical cancer. The company’s Venezia device is designed to facilitate pre-defined, consistent needle placement for interstitial brachytherapy and to allow operating clinicians the ability to access tumors that extend outside of the […]
